help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on September 20, 2007
Endocrinology, doi:10.1210/en.2007-0645
A more recent version of this article appeared on January 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
149/1/320    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ziegler, C. G.
Right arrow Articles by Krug, A. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ziegler, C. G.
Right arrow Articles by Krug, A. W.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*DOPAMINE
Medline Plus Health Information
*Pheochromocytoma

Submitted on May 15, 2007
Accepted on September 12, 2007

Dehydroepiandrosterone (DHEA) induces a neuroendocrine phenotype in nerve growth factor (NGF)-stimulated chromaffin pheochromocytoma PC12 cells

Christian G. Ziegler, Flavie Sicard, Peter Lattke, Stefan R. Bornstein, Monika Ehrhart-Bornstein, and Alexander W. Krug*

Carl Gustav Carus University Hospital, Medical Clinic III, University of Dresden, Germany, and Carl Gustav Carus University Hospital, Institute of Clinical Chemistry and Laboratory Medicine

* To whom correspondence should be addressed. E-mail: alexander.krug{at}uniklinikum-dresden.de.

The adrenal androgen dehydroepiandrosterone (DHEA) is produced in the inner zone of the adrenal cortex which is in direct contact to adrenal medullary cells. Due to their close anatomical proximity and tightly intermingled cell borders a direct interaction of adrenal cortex and medulla has been postulated. In humans congenital adrenal hyperplasia due to 21-hydroxylase (OH) deficiency results in androgen excess accompanied by severe adrenomedullary dysplasia and chromaffin cell dysfunction. Therefore, in order to define the mechanisms of DHEA action on chromaffin cell function, we investigated its effect on cell survival and differentiation processes on a molecular level in the chromaffin cell line PC12.

DHEA lessened the positive effect of NGF on cell survival and neuronal differentiation. NGF-mediated induction of a neuronal phenotype was inhibited by DHEA as indicated by reduced neurite outgrowth and decreased expression of neuronal marker proteins such as SNAP-25 and VAMP-2. We examined whether DHEA may stimulate the cells towards a neuroendocrine phenotype. DHEA significantly elevated catecholamine release from unstimulated PC12 cells in the presence, but not in the absence of NGF. Accordingly, DHEA enhanced the expression of the neuroendocrine marker protein chromogranin A. Next, we explored the possible molecular mechanisms of DHEA and NGF interaction. We demonstrate that NGF-induced ERK1/2 phosphorylation was reduced by DHEA.

In summary, our data show that DHEA influences cell survival and differentiation processes in PC12 cells, possibly by interacting with the ERK1/2 MAPK pathway. DHEA drives NGF-stimulated cells towards a neuroendocrine phenotype, suggesting that the interaction of intraadrenal steroids and growth factors is required for the maintenance of an intact adrenal medulla.


Key words: Dehydroepiandrosterone (DHEA) • nerve growth factor (NGF) • pheochromocytoma PC12 cells • mitogen activated protein kinases ERK1/2







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society